https://ir.definiumtx.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_354426f606269984c271309319e3bc85/mindmed/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.definiumtx.com/news-events/press-releases/detail/252/definium-therapeutics-announces-new-employee-inducement-grants Mon, 28 Sep 26 16:01:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/252/definium-therapeutics-announces-new-employee-inducement-grants https://ir.definiumtx.com/news-events/press-releases/detail/251/definium-therapeutics-announces-positive-topline-results-from-phase-3-panorama-study-of-dt120-odt-in-generalized-anxiety-disorder Mon, 14 Sep 26 07:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/251/definium-therapeutics-announces-positive-topline-results-from-phase-3-panorama-study-of-dt120-odt-in-generalized-anxiety-disorder https://ir.definiumtx.com/news-events/press-releases/detail/250/definium-therapeutics-announces-new-employee-inducement-grants Mon, 14 Sep 26 06:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/250/definium-therapeutics-announces-new-employee-inducement-grants https://ir.definiumtx.com/news-events/press-releases/detail/249/definium-therapeutics-to-discuss-topline-results-from-phase-3-panorama-study-in-generalized-anxiety-disorder-on-september-14-2026 Sun, 13 Sep 26 17:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/249/definium-therapeutics-to-discuss-topline-results-from-phase-3-panorama-study-in-generalized-anxiety-disorder-on-september-14-2026 https://ir.definiumtx.com/news-events/press-releases/detail/248/definium-therapeutics-to-present-topline-data-from-phase-3-emerge-and-voyage-trials-across-major-depressive-disorder-and-generalized-anxiety-disorder-at-psych-congress-2026 Thu, 10 Sep 26 07:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/248/definium-therapeutics-to-present-topline-data-from-phase-3-emerge-and-voyage-trials-across-major-depressive-disorder-and-generalized-anxiety-disorder-at-psych-congress-2026 https://ir.definiumtx.com/news-events/press-releases/detail/247/definium-therapeutics-receives-breakthrough-therapy-designation-for-dt120-lysergide-orally-disintegrating-tablet-odt-in-major-depressive-disorder-mdd-following-positive-phase-3-results Tue, 08 Sep 26 07:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/247/definium-therapeutics-receives-breakthrough-therapy-designation-for-dt120-lysergide-orally-disintegrating-tablet-odt-in-major-depressive-disorder-mdd-following-positive-phase-3-results https://ir.definiumtx.com/news-events/press-releases/detail/246/definium-therapeutics-announces-new-employee-inducement-grants Mon, 31 Aug 26 16:01:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/246/definium-therapeutics-announces-new-employee-inducement-grants https://ir.definiumtx.com/news-events/press-releases/detail/245/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events Wed, 26 Aug 26 07:01:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/245/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events https://ir.definiumtx.com/news-events/press-releases/detail/244/definium-therapeutics-announces-new-employee-inducement-grants Mon, 17 Aug 26 16:01:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/244/definium-therapeutics-announces-new-employee-inducement-grants https://ir.definiumtx.com/news-events/press-releases/detail/243/definium-therapeutics-announces-positive-topline-results-from-phase-3-voyage-study-of-dt120-odt-in-generalized-anxiety-disorder Wed, 12 Aug 26 07:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/243/definium-therapeutics-announces-positive-topline-results-from-phase-3-voyage-study-of-dt120-odt-in-generalized-anxiety-disorder